Download Citation
Article Source:
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer
Lin ZP,
Zhu YL,
Lo YC,
Moscarelli J,
Xiong A,
et al.
(2018)
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.
PLOS ONE 13(11): e0207399.
https://doi.org/10.1371/journal.pone.0207399